Insulin Resistance
By FormBlends Medical Team · Last reviewed April 2026
Insulin resistance is a metabolic condition in which cells fail to respond normally to insulin, forcing the pancreas to produce more insulin to maintain blood sugar control. It is a precursor to type 2 diabetes and affects over 40% of adults aged 18 to 44 in the United States. GLP-1 receptor agonists and metabolic peptides are among the most effective interventions studied for this condition.
Affects over 40% of US adults aged 18 to 44
FormBlends Condition Context
Reviewed May 14, 2026Use Insulin Resistance condition guide as a decision-support page, not a shortcut. Its job is to connect symptoms and treatment options to a safer provider conversation, especially where the search overlaps with condition-specific care. A useful reader should leave with better questions about clinician oversight, evidence quality, safety limits, cost, pharmacy path, and what changes for their own health history.
- Confirm whether the page is discussing approved care, compounded access, off-label use, or research-only context.
- Check the date, evidence quality, safety limits, and whether newer clinical or regulatory updates may change the answer.
- Ask a licensed clinician how the information applies to your history, medications, labs, goals, and risk profile.
Common Symptoms
- Elevated fasting blood glucose or HbA1c levels
- Increased waist circumference and visceral fat
- Fatigue after meals, especially high-carb meals
- Skin tags and acanthosis nigricans (darkened skin patches)
- Difficulty losing weight despite caloric restriction
- Increased hunger and carbohydrate cravings
Common Causes
- Excess visceral adiposity producing inflammatory cytokines
- Sedentary lifestyle reducing glucose uptake in muscle
- Chronic high-carbohydrate diet overwhelming insulin signaling
- Genetic predisposition affecting insulin receptor sensitivity
- Chronic sleep deprivation impairing glucose metabolism
Treatment Options
Semaglutide
Semaglutide improves insulin sensitivity through weight loss and direct effects on pancreatic beta-cell function, reducing fasting glucose and HbA1c levels.
Learn more about Semaglutide →Tirzepatide
Tirzepatide acts on both GIP and GLP-1 receptors, producing greater improvements in insulin sensitivity and glycemic control than single-agonist therapies in clinical trials.
Learn more about Tirzepatide →MOTS-c
MOTS-c activates AMPK pathways that improve glucose uptake in skeletal muscle and enhance metabolic flexibility independent of insulin signaling.
Learn more about MOTS-c →Dietary Intervention
Reducing refined carbohydrate intake, increasing protein and fiber, and implementing time-restricted eating can meaningfully improve insulin sensitivity within weeks.
Find Treatment for Insulin Resistance
Browse clinics near you that treat insulin resistance.
Find Clinics